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Figure 1. Schematic Representation of Cas-
pase Recruitment Domain Proteins that Cou-
ple Antigen Receptor Signals to NF-B Acti-
vation
CARD is shown in blue at the N termini. Bcl10
contains a C-terminal domain rich in serines
and threonines (S/T). CARMA-1 contains, in
addition to CARD, a coiled-coil domain (CC,
pink), and PDZ (yellow), SH3 (black), and gua-
nylate kinase (GUK, green) domains. The un
mutation identified by Jun et al. is a single
amino acid change within the CC domain of
CARMA-1 as indicated.
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In this issue of Immunity, Neild and Roy (2003) examine
the intracellular life of Legionella pneumophila in den-Abul K. Abbas1 and Ranjan Sen2
1Department of Pathology dritic cells (DC) and macrophages, as well as the pre-
sentation of its antigens to CD4 T cells. LegionellaUniversity of California San Francisco School
of Medicine is a particularly interesting bacterium because of the
peculiarities inherent in its intracellular sojourn inSan Francisco, California 94143
2 Rosenstiel Research Center and Department phagocytes: it resides in an unusual vesicle character-
ized by ribosomes studded along its walls (Horwitz,of Biology
Brandeis University 1983). In this compartment, Legionella proteins en-
coded by the dot gene inhibit phagosome-lysosomeWaltham, Massachusetts
Previews
723
fusion and endosomal acidification, yielding a vesicu- reviewing the processing of proteins associated with live
intracellular bacteria. Most data on antigen processinglar structure conducive to the multiplication of Legio-
come from analyses of single purified proteins takennella, poor in lysosomal contents, and in MHC mole-
into the antigen-presenting cells (APC) by either fluidcules.
phase endocytosis or receptor mediated uptake. To sim-
plify, this processing involves the transport of the proteinNeild and Roy now report that while nonactivated mac-
antigen by the vesicular system into lysosomal-like vesi-rophages are permissive for Legionella growth, patho-
cles where the proteins are unfolded and then assem-gen replication is severely restricted in DC. Moreover,
bled onto nascent class II-MHC molecules arriving inthe microbe can elicit CD4 T cell responses, indicating
these compartments in a complex with the invariantthat some protein antigens become accessible to pro-
chain. Proteolysis of the invariant chain, denaturationcessing and selection of their peptides by the class II-
with or without partial proteolysis of the protein antigen,MHC pathway, presumably in these same DC in which
and assembly of the peptide-MHC complex, helped byLegionella fares poorly. These new findings raise two
auxiliary molecules like H2-M (HLA-DM), are other stepsimportant issues: first, the mean(s) by which DC control
in this process. Short peptides and some proteins thatthe intracellular replication of the bacteria and, second,
have conformational flexibility can also assemble in re-the mechanisms involved in the processing of antigens
cycling endocytic vesicles, based on exchange with therelevant to virulent Legionella.
existing peptide cargo of mature class II-MHC mole-Microbicidal Mechanisms
cules.The present paper does not determine how DC restrict
This scenario has to be modified when discussing thethe growth of Legionella. Despite the striking differences
presentation of microbial proteins. First, microbes arein bacterial replication, the organisms exist in a similar
taken into phagocytic vacuoles, which are plastic struc-type of ER-derived vesicle in both DC and macrophages,
tures that undergo extensive remodeling as they sojournraising the question of what differences might character-
through the cytoplasm. The flow of vesicles into and outize the pathogen vesicles in the two cell types. In DC,
of the phagosome may vary, with significant implicationsthe restriction of growth seems independent of the
for the content of various proteins of the class II-MHCtransport of Legionella to a lysosome, in accord with
pathway and of proteolytic enzymes. For example, Hard-previous studies showing that interferon- treated mac-
ing’s laboratory has observed that large particle-bearingrophages inhibited Legionella multiplication but that the
phagosomes contain both MHC molecules from the re-Legionella ER-derived phagosome was maintained
cycling pool as well as recently-arrived molecules from(Bhardwaj et al. 1986). Furthermore, known mediators
ER (Ramachandra et al., 1999).of microbicidal effects such as reactive oxygen or nitrate
Intracellular pathogens also contain multiple proteinsintermediates have been examined without convincing
distributed among various anatomical compartments,evidence that any of them is a key effector. Clearly a
including integral membrane proteins, cytosolic mole-careful comparison of the composition of the Legionella
cules, and soluble material secreted into the phagocyticvesicle of permissive macrophages with that of nonper-
vacuole. One would expect that there will not only be
missive DC—or for that matter, with that of the inter-
differences in the processing of these proteins due to
feron- treated macrophage—is needed to determine
differential access to processing enzymes and to MHC
the unknown factor or factors responsible for controlling
molecules, but also competition among them and their
the replication of the bacteria. The ER-phagosome that
derived peptides for interaction with the class II-MHC
harbors the Legionella is a highly dynamic structure system. The upshot may be a much more extensive
(Sturgill-Koszycki and Swanson, 2000; Kagan and Roy, and varied repertoire of presented microbial peptides as
2002) and the entry to, and flow from it, of various pro- compared to what is observed using individual protein
teins that might serve to inhibit bacterial growth may antigens.
vary greatly between DC and the monocytes/macro- A third important feature of antigen presentation by
phages. Alternatively, the phagosomes in DC may sim- pathogen-infected cells is that by altering the normal
ply lack molecules necessary for Legionella multiplica- vesicular trafficking to phagosomes, the infecting organ-
tion. The application of proteomics to intracellular isms may influence the antigen processing and presen-
vesicles will be a useful approach to this important issue, tation machinery. Legionella is just one striking example
as already demonstrated by the initial studies from Des- of this phagosome modification process, first reported
jardin’s laboratory (Garin et al., 2001). for M tuberculosis by Armstrong and Hart (1971; re-
Antigen Presentation viewed in Sinai and Joiner, 1997), but how such events
CD4 T cells from Legionella-infected mice produced influence antigen presentation remains murky.
interferon- when incubated with either infected DC or In this new work, Neild and Roy showed that the pre-
macrophages, but the T cell response to cells infected sentation of Legionella peptides is a late event occurring
with wild-type versus dotA mutants appears different, some time between 1 hr, their first point, and 17 hr. This
which leads to several questions. Is the ER-derived long gap in the analysis makes it difficult to critically
vesicle the site of processing and peptide-MHC assem- correlate the anatomical localization of the microbe with
bly or do Legionella proteins enter other processing the site of processing; the site of assembly of the Legio-
compartments? Are the antigens presented to CD4 nella peptides with MHC molecule may not necessarily
T cells by cells infected with wild-type bacteria distinct be at the site where the bacterium is located. Some
from those presented by cells infected with nonvirulent proteins could exit from the ER-derived vesicle con-
organisms that enter lysosomes, as Neild and Roy taining Legionella to reach other vesicles containing
suggest? class II-MHC molecules. A second difficulty with corre-
lating intracellular localization with presentation lies withIn considering these issues it is worthwhile briefly
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the T cell system in itself and its very high sensitivity to A major function for CD40 on B cells is to transmit signals
from CD40L (CD154) helper T cells to follicular (FO) Bpeptide-MHC complexes. Since the T cells can respond
cells. These responses to T cell-dependent (TD) anti-in vivo to a handful of peptide-MHC complexes per APC
gens (Ags) lead to germinal center (GC) formation fol-(for example, DiPaolo and Unanue, 2002), many intracel-
lowed by memory B cell formation (Clark and Ledbetter,lular routes, regardless of their efficiency, and many
1994; Grewal and Flavell, 1998). End of story? Not quite.peptides, regardless of their affinity for MHC molecules,
A number of puzzles remain, including the function ofcan produce enough T cell receptor ligands to trigger
CD40 on memory B cells and splenic marginal zone (MZ)a response.
B cells. MZ B cells contain both IgM memory B cellsThese points are all relevant to a critical issue, namely
and B cells designed to respond rapidly to T cell-inde-the extent to which the antigens presented by cells in-
pendent type 2 (TI-2) polysaccharide Ags. Interestingly,fected with wild-type versus avirulent dotA mutants
they proliferate much better in response to CD40 ligationoverlap. Does the fusion with lysosomes in the latter
and are better Ag-presenting cells than FO B cells (Olivercase change the set of peptides presented by the class
et al., 1997). In contrast, FO B cells respond better toII molecules and what does this mean for vaccine ap-
TI-1-like stimuli. Memory B cells respond to and mayproaches? Likewise, does the difference in vesicular
be recruited to the MZ by polysaccharides and otherenvironment alter gene expression and hence, antigenic
bacterial products such as CpG DNA (Vinuesa et al.,profile? The implications of there being microbial anti-
2003; Bernasconi et al., 2002). Overall, the roles CD40-gens that are expressed and/or processed only under
expressing B cells play during inflammatory responsessome circumstances are of considerable importance.
and in the MZ are not well understood.The system described by Neild and Roy comparing DC
Clearly CD40 on B cells can do more than simply driveand macrophages and the wild-type and dotA mutants
FO B cells to become memory B cells. Yasui et al. (2002)of Legionella is ideal to examine the intracellular steps
in an elegant study have shown that the cytoplasmicin presentation of microbial antigens, as well as their
tail of CD40 has two distinct functional domains—onebiological relevance.
for induction of extrafollicular B cells in periarteriolar
lymphoid sheaths (PALS) and the start of GC formation,
Emil R. Unanue and another for GC formation. So like other TNF receptor
Department of Pathology and Immunology family members, CD40 has the wiring to mediate several
Washington University School of Medicine functions.
St. Louis, Missouri 63110 The findings of Brodeur et al. suggest that the CD40
pathway may be influenced by changes during innate
immune responses. They report that the disulfide-linkedSelected Reading
heptamer, C4BP, which is regulated by inflammatory
cytokines, could bind to CD40 on B cells and activateArmstrong, J., and Hart, P.D. (1971). J. Exp. Med. 134, 713–740.
them. C4BP did not bind to B cells from a CD40-deficientBhardwaj, N., Nash, T.W., and Horwitz, M.A., (1986). J. Immunol.
hyper IgM (HIGM) syndrome patient or activate B cells137, 2662–2669.
missing a key component of the CD40 signaling path-DiPaolo, R.J., and Unanue, E.R. (2002). J. Immunol. 169, 1–4.
way, IKK/NEMO. In the presence of IL-4, C4BP likeGarin, J., Diez, R., Kieffer, S., Dermine, J.F., Duclos, S., Gagnon, E.,
CD154 caused isotype switching to IgE. And B cell-Sadoul, R., Rondeau, C., and Desjardins, M. (2001). J. Cell Biol. 152,
165–180. derived CD40L was not required for C4BP to induce
proliferation or isotype switching. Thus, based on a num-Horwitz, M.A. (1983). J. Exp. Med. 158, 1319–1331.
ber of criteria, C4BP directly activates the CD40 pathwayKagan, J.C., and Roy, C.R. (2002). Nat. Cell Biol. 4, 945–954.
in B cells.Neild, A.L., and Roy, C.R. (2003). Immunity 18, this issue, 813–823.
A major function of C4BP is to bind to and promoteRamachandra, L., Noss, E., Boom, W.H., and Harding, C.V. (1999).
the decay and degradation of C4b, a component of theCellular Microbiology 1, 205–214.
classical complement pathway C3 convertase, C4bC2aSinai, A.P., and Joiner, K.A. (1997). Annu. Rev. Microbiol. 51,
(Lindahl et al., 2000). C4BP is a soluble protein with 6415–462.
or 7  chains attached together at a base like a “fan,”Sturgill-Koszycki, S., and Swanson, M.S. (2000). J. Exp. Med. 192,
with or without a short  chain. Like other complement1261–1272.
binding proteins such as CR1/CD35 and CR2/CD21, the
C4BP heptamer (71) is made up of a string of short
consensus repeats (SCRs) or complement control pro-
tein (CCP) modules. Each SCR (8 in each  chain and
A CD40 Bridge between 3 in the  chain) has 60 amino acid residues and 4
highly conserved cysteines, which form intrachain disul-Innate and Adaptive Immunity
fide bridges. C4BP binds to CD40 via its  chains, so
one can envision “open fan” C4BP heptamers potentially
being even more efficient than CD154 trimers in activat-
In this issue of Immunity, Brodeur et al. show that C4b ing B cells.
binding protein (C4BP), a regulator component of the Binding of C4BP did not block the binding of CD40L
classical complement (C) pathway, can bind to CD40 to B cells and vice versa. This suggests that CD154 and
receptors on B cells and activate them. This suggests C4BP bind to distinct sites on CD40, and therefore,
a novel way by which CD40 may function to bridge theoretically could act together to affect B cell matura-
tion. Further studies are required to determine the rela-innate and adaptive immune responses.
